1. Home
  2. EVC vs STTK Comparison

EVC vs STTK Comparison

Compare EVC & STTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Entravision Communications Corporation

EVC

Entravision Communications Corporation

HOLD

Current Price

$3.47

Market Cap

273.8M

Sector

Industrials

ML Signal

HOLD

Logo Shattuck Labs Inc.

STTK

Shattuck Labs Inc.

HOLD

Current Price

$6.00

Market Cap

275.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVC
STTK
Founded
1996
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Broadcasting
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
273.8M
275.9M
IPO Year
2000
2020

Fundamental Metrics

Financial Performance
Metric
EVC
STTK
Price
$3.47
$6.00
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
$6.20
AVG Volume (30 Days)
204.4K
471.0K
Earning Date
01-01-0001
06-11-2026
Dividend Yield
6.62%
N/A
EPS Growth
47.59
53.02
EPS
N/A
N/A
Revenue
$536,034,000.00
$1,000,000.00
Revenue This Year
$64.06
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.71
$0.69
52 Week High
$3.44
$5.20

Technical Indicators

Market Signals
Indicator
EVC
STTK
Relative Strength Index (RSI) 68.04 81.23
Support Level $2.83 $1.76
Resistance Level N/A N/A
Average True Range (ATR) 0.13 0.36
MACD 0.03 0.17
Stochastic Oscillator 70.48 99.54

Price Performance

Historical Comparison
EVC
STTK

About EVC Entravision Communications Corporation

Entravision Communications Corp owns and operates Spanish language television and radio stations in the United States. The Company also owns and operates a smaller group of television stations that broadcast English language programming and has operations that provide programmatic advertising technology and services. The Company has organized its operations into two reportable segments. Its media segment includes its television, radio, and digital marketing operations. Its advertising and technology services segment provides programmatic advertising and technology services. The company generates the majority of its revenue from the Media segment. Geographically, the company generates the majority of its revenue from the United States.

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

Share on Social Networks: